- Joined
- Dec 5, 2015
- Messages
- 28,588
- Reaction score
- 6,363
- Location
- Washington
- Gender
- Male
- Political Leaning
- Independent
At less than $10 a shot, the relatively low-cost vaccine touted by Russia’s leadership has rapidly gained approval in developing countries as many regions experience second and third waves of the virus. Among the countries that have approved it for use are Argentina, Bolivia, Serbia, Hungary, the UAE, Iran, Iraq, Lebanon, Bahrain, Egypt, Iraq, Myanmar, Pakistan, Kazakhstan, the Republic of the Congo, Vietnam and the Philippines. Russia’s health authorities declared its efficacy rate at 91.6%.
The Lancet in February reported the Russian jab’s high efficacy rate in late stage clinical trials, writing that Sputnik V’s “vaccine efficacy, based on the numbers of confirmed COVID-19 cases from 21 days after the first dose of vaccine, is reported as 91.6%, and the suggested lessening of disease severity after one dose is particularly encouraging for current dose-sparing strategies.”
India becomes 60th country to authorize use of Russia's Sputnik V vaccine
The authorization comes as India faces a devastating new surge of Covid infections.
www.cnbc.com
Russia already is close to delivering the Sputnik light as well, the one-shot version of the vaccine.
The results have been very promising and the vaccine is very cost-effective. I think there needs to be some sort of global consensus. Countries like Brazil and India will benefit a lot from Sputnik V and Sputnik Light.